Middle East CIO — Pharma & Biotech (Regional Leadership)

Position overview

Gladwin International Leadership Advisors is representing a confidential organisation in Pharmaceuticals & Biotechnology on a senior CIO leadership mandate anchored in Middle East. The remit explicitly spans Malaysia, India, USA.

This is a sector or practice-head mandate combining deep domain credibility with commercial ownership of a vertical P&L or global practice line.

You will be measured on outcomes that compound: talent depth, customer trust, and a balance sheet that can flex through cycles.

---

Context you will inherit

• Market & sector: Biosimilars and specialty pharma commercialisation — moving from commoditised generics to branded specialty requires entirely new commercial leadership capabilities
• Geographic spine: Primary hub Middle East with explicit corridor responsibility across Malaysia, India, USA.
• Organisation stage: Customer concentration in a handful of strategic accounts shapes both opportunity and reputational risk.
• Stakeholders: Key interfaces include headquarters strategy, regional risk and legal, local regulators (where material), and anchor channel partners.
• Secondary lens: R&D and innovation leadership — transitioning from generic-follow business models to differentiated, IP-rich innovation pipelines requires a different type of scientific and commercial leadership

---

The mandate (12–24 month arc)

1. Identity & access: Clean up excessive privileges and stale accounts — foundational for both security and audit.
2. End-user support: Reduce ticket backlog through root-cause fixes, not perpetual firefighting.
3. Asset lifecycle: Refresh hardware and end-of-life software on a predictable cadence.
4. Business continuity: Tabletop exercises that surface real gaps in dependencies and communications.
5. Innovation intake: Lightweight process for business-led experiments that don’t bypass architecture guardrails.
6. Vendor concentration: Mitigate single-supplier risk for critical platforms.

---

Responsibilities (representative)

• Improve IT demand management and portfolio governance with the executive committee.
• Upgrade vendor management — SLAs, penalties, and outcome-based contracts.
• Sponsor integration discipline post-M&A for systems and data.
• Build IT financial transparency — chargeback or showback where helpful.
• Develop IT leadership team with mix of supplier management and internal delivery strength.

---

Leadership profile

• Communication: Executive presence in English; additional languages valued where market-relevant.
• Education: Strong undergraduate grounding; MBA / advanced degree / professional qualification common at this level.
• Judgment: High signal-to-noise under pressure; ethical clarity; willingness to halt initiatives that break risk appetite.
• Service leadership: IT organisation trusted for reliability, cost transparency, and partnership.
• Geographic muscle: Comfort operating from Middle East with regular engagement across Malaysia, India.

---

Team & culture

Inclusion and psychological safety are not separate programmes — they are prerequisites for honest debate on strategy and risk. Model curiosity, direct feedback, and consequences for conduct lapses.

---

Success measures (examples)

• Growth quality: Mix of recurring revenue, new logos, and cross-sell — not volume for its own sake.
• Productivity: Unit cost, automation savings, or throughput improvements with audited baselines.
• Customer: NPS / CSAT where tracked; contract renewals; reference-ability in strategic accounts.
• Franchise: Clean compliance record; reputation stability in industry and government forums.

---

First 90 days (orientation arc)

• Days 1–30: Listening tour — customers, regulators (as appropriate), top team 1:1s, and unfiltered view of numbers; pause major reorganisation.
• Days 30–60: Publish a short memo on priorities, non-goals, and decision rights; align executive committee on three enterprise bets.
• Days 60–90: Lock operating cadence; fill or upgrade one to two critical seats; deliver one visible win (customer, cost, or culture).
• Commission a pragmatic view of data, cyber, and automation posture; sponsor one bounded pilot with ROI hypothesis.
• Establish escalation discipline with matrix partners — fewer meetings, clearer decision logs.

---

Stakeholder map (illustrative)

• Internal: CEO or regional president, CFO, risk / legal, CHRO, CIO or CDO, business GMs, internal audit.
• External: Strategic accounts, channel partners, industry associations, regulators (where material).
• Owners: PE operating partners, promoter office, or public investors — pace and clarity matter as much as vision.

---

Travel & mobility

Multi-hub rhythm — plan for weekly or bi-weekly cross-border travel during integration or transformation peaks.

---

Compensation

Market-aligned CIO remuneration in Pharmaceuticals & Biotechnology with performance linkage; sign-on and relocation considered for exceptional fits.

---

Application process

Gladwin International is managing this search confidentially. Shortlisted candidates will engage in structured conversations with the firm’s partners before client introduction. Please apply through the careers portal with a concise note on why this geography, sector, and remit fit your trajectory.

We review every submission personally; unsolicited outreach to the end client is discouraged and may disqualify candidacy.

---

Reference: pharmaceuticals-biotech · CIO · Middle East · Gladwin International Leadership Advisors